Effect of Combined Sex Hormone Replacement on Bone/cartilage Turnover in a Murine Model of Osteoarthritis

Overview

Journal Clin Orthop Surg

Specialty Orthopedics

Date 2012 Sep 6

PMID 22949956

Citations 9

Authors

Jae-Hyuk Yang

Ji-Hun Kim

Deuk-Soo Lim

Kwang-Jun Oh

Affiliations

Soon will be listed here.

Abstract

Background: Estrogens act on estrogen receptors distributed in articular cartilages, synovial membrane, and ligaments, which are thought to be related with degenerative changes. Meanwhile, progesterone is known to have a weak anabolic action on bone formation This study evaluates the effects of estrogen and progesterone hormone on bone/cartilage turnover in ovariectomized (OVX) rats.

Methods: Thirty-five 7-month-old female Sprague-Dawley rats were randomly divided into 5 groups and then ovariectomized bilaterally except the sham control group. The first and the second group acting as controls did not receive hormonal therapy, the third group received estrogen, the fourth group received progesterone, and the fifth group received combination of both hormones 10 weeks after surgery. Evaluations were done using the serum levels of cartilage oligomeric matrix protein (COMP) for cartilage turnover, collagen type I C-telopeptide (CTX-1) and osteocalcin (OC) for bone turnover at 11, 15, 19 weeks after OVX and histology using the Osteoarthritis Research Society International (OARSI) osteoarthritis (OA) cartilage histopathology assessment system.

Results: Significantly less cartilage degradation (decreased levels of COMP) was found in the combined hormone treated group in comparison with OVX group. Similarly, both hormonal treatment resulted in increased bone formation and decreased bone resorption i.e., a low overall bone turnover status (decrease in the serum OC and CTX-1 levels).

Conclusions: Combined estrogen and progesterone therapy was found to be convincing in terms of reducing the severity of OA in this experimental model.

Citing Articles

Low back pain and osteoarthritis pain: a perspective of estrogen.

Pang H, Chen S, Klyne D, Harrich D, Ding W, Yang S Bone Res. 2023; 11(1):42.

PMID: 37542028 PMC: 10403578. DOI: 10.1038/s41413-023-00280-x.

Zoledronic acid generates a spatiotemporal effect to attenuate osteoarthritis by inhibiting potential Wnt5a-associated abnormal subchondral bone resorption.

Ding D, Wang L, Yan J, Zhou Y, Feng G, Ma L PLoS One. 2022; 17(7):e0271485.

PMID: 35900969 PMC: 9333271. DOI: 10.1371/journal.pone.0271485.

Metformin attenuates osteoclast-mediated abnormal subchondral bone remodeling and alleviates osteoarthritis via AMPK/NF-κB/ERK signaling pathway.

Guo H, Ding D, Wang L, Yan J, Ma L, Jin Q PLoS One. 2021; 16(12):e0261127.

PMID: 34914744 PMC: 8675877. DOI: 10.1371/journal.pone.0261127.

Sex Steroids and Osteoarthritis: A Mendelian Randomization Study.

Yan Y, Qu Z, Yu D, Wang W, Yan S, Huang H Front Endocrinol (Lausanne). 2021; 12:683226.

PMID: 34248845 PMC: 8261132. DOI: 10.3389/fendo.2021.683226.

Relationship between hormone replacement therapy and spinal osteoarthritis: a nationwide health survey analysis of the elderly Korean population.

Park J, Hong J, Han K, Han S, Chun E BMJ Open. 2017; 7(11):e018063.

PMID: 29127229 PMC: 5695470. DOI: 10.1136/bmjopen-2017-018063.

References

Ekman S, Reinholt F, Hultenby K, Heinegard D . Ultrastructural immunolocalization of cartilage oligomeric matrix protein (COMP) in porcine growth cartilage. Calcif Tissue Int. 1997; 60(6):547-53. DOI: 10.1007/s002239900278. View

Pritzker K, Gay S, Jimenez S, Ostergaard K, Pelletier J, Revell P . Osteoarthritis cartilage histopathology: grading and staging. Osteoarthritis Cartilage. 2005; 14(1):13-29. DOI: 10.1016/j.joca.2005.07.014. View

Zhou H, Shen V, Dempster D, Lindsay R . Continuous parathyroid hormone and estrogen administration increases vertebral cancellous bone volume and cortical width in the estrogen-deficient rat. J Bone Miner Res. 2001; 16(7):1300-7. DOI: 10.1359/jbmr.2001.16.7.1300. View

Sorensen M, Henriksen K, Schaller S, Karsdal M . Biochemical markers in preclinical models of osteoporosis. Biomarkers. 2007; 12(3):266-86. DOI: 10.1080/13547500601070842. View

Wluka A, Davis S, Bailey M, Stuckey S, Cicuttini F . Users of oestrogen replacement therapy have more knee cartilage than non-users. Ann Rheum Dis. 2001; 60(4):332-6. PMC: 1753592. DOI: 10.1136/ard.60.4.332. View

Gundberg C . Biochemical markers of bone formation. Clin Lab Med. 2000; 20(3):489-501. View

Brouwer G, van Tol A, Bergink A, Belo J, Bernsen R, Reijman M . Association between valgus and varus alignment and the development and progression of radiographic osteoarthritis of the knee. Arthritis Rheum. 2007; 56(4):1204-11. DOI: 10.1002/art.22515. View

Sniekers Y, Weinans H, Bierma-Zeinstra S, van Leeuwen J, van Osch G . Animal models for osteoarthritis: the effect of ovariectomy and estrogen treatment - a systematic approach. Osteoarthritis Cartilage. 2008; 16(5):533-41. DOI: 10.1016/j.joca.2008.01.002. View

. Effects of hormone therapy on bone mineral density: results from the postmenopausal estrogen/progestin interventions (PEPI) trial. The Writing Group for the PEPI. JAMA. 1996; 276(17):1389-96. View

10.

Ham K, Loeser R, Lindgren B, Carlson C . Effects of long-term estrogen replacement therapy on osteoarthritis severity in cynomolgus monkeys. Arthritis Rheum. 2002; 46(7):1956-64. DOI: 10.1002/art.10406. View

11.

Turner A, Athanasiou K, Zhu C, Alvis M, Bryant H . Biochemical effects of estrogen on articular cartilage in ovariectomized sheep. Osteoarthritis Cartilage. 1997; 5(1):63-9. DOI: 10.1016/s1063-4584(97)80032-5. View

12.

Sherman S, Smith Jr J, Tobin J, Soares Jr J . Ovariectomy, dietary zinc, and bone metabolism in retired breeder rats. Am J Clin Nutr. 1989; 49(6):1184-91. DOI: 10.1093/ajcn/49.6.1184. View

13.

Felson D, Zhang Y, Hannan M, Naimark A, Weissman B, Aliabadi P . The incidence and natural history of knee osteoarthritis in the elderly. The Framingham Osteoarthritis Study. Arthritis Rheum. 1995; 38(10):1500-5. DOI: 10.1002/art.1780381017. View

14.

Karsdal M, Hjorth P, Henriksen K, Kirkegaard T, Nielsen K, Lou H . Transforming growth factor-beta controls human osteoclastogenesis through the p38 MAPK and regulation of RANK expression. J Biol Chem. 2003; 278(45):44975-87. DOI: 10.1074/jbc.M303905200. View

15.

Oliveria S, Felson D, REED J, Cirillo P, Walker A . Incidence of symptomatic hand, hip, and knee osteoarthritis among patients in a health maintenance organization. Arthritis Rheum. 1995; 38(8):1134-41. DOI: 10.1002/art.1780380817. View

16.

Clark A, Jordan J, Vilim V, Renner J, Dragomir A, Luta G . Serum cartilage oligomeric matrix protein reflects osteoarthritis presence and severity: the Johnston County Osteoarthritis Project. Arthritis Rheum. 1999; 42(11):2356-64. DOI: 10.1002/1529-0131(199911)42:11<2356::AID-ANR14>3.0.CO;2-R. View

17.

Dietrich W, Haitel A, Holzer G, Huber J, Kolbus A, Tschugguel W . Estrogen receptor-beta is the predominant estrogen receptor subtype in normal human synovia. J Soc Gynecol Investig. 2006; 13(7):512-7. DOI: 10.1016/j.jsgi.2006.07.002. View

18.

Otterness I, Swindell A, Zimmerer R, Poole A, Ionescu M, Weiner E . An analysis of 14 molecular markers for monitoring osteoarthritis: segregation of the markers into clusters and distinguishing osteoarthritis at baseline. Osteoarthritis Cartilage. 2000; 8(3):180-5. DOI: 10.1053/joca.1999.0288. View

19.

Schmidt I, Wakley G, Turner R . Effects of estrogen and progesterone on tibia histomorphometry in growing rats. Calcif Tissue Int. 2000; 67(1):47-52. DOI: 10.1007/s00223001096. View

20.

Sniekers Y, Intema F, Lafeber F, van Osch G, van Leeuwen J, Weinans H . A role for subchondral bone changes in the process of osteoarthritis; a micro-CT study of two canine models. BMC Musculoskelet Disord. 2008; 9:20. PMC: 2259345. DOI: 10.1186/1471-2474-9-20. View